Delivery Order SPE2DB20D1100-SPE2DB25FD7Z0
- Not listed
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $199.02 firm fixed price delivery order contract to supply 4561475224 PLAQUENIL 200 MG TABLET 100S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania within the one day period of July 12-13, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to support the...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $548 to supply 100 tablets of the drug Plaquenil. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in July 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver this order of the malaria drug to support the Agency's stockpile needs. No subcontractors or set...
- The Defense Logistics Agency awarded a $363,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 200 tablets each of Plaquenil, an antimalarial drug. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 19, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands. This...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one thousand two hundred fifty-two dollars and six cents ($1,252.06) to supply one hundred (100) tablets of the pharmaceutical Plaquenil (hydroxychloroquine sulfate) 200mg to the Defense Logistics Agency Troop Support Medical (DLA). Performance will take place in Conshohocken, Pennsylvania over a period of three (3) days from August 18 through...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,711.53 firm fixed-price contract is for the delivery of 100 tablets of the drug Plaquenil (hydroxychloroquine sulfate 200 mg) to Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00...
- The Defense Logistics Agency Troop Support Medical awarded a $318,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of the prescription drug Plaquenil (hydroxychloroquine sulfate) 200 mg tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 21, 2023 through August 22, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $96,056.33, is for the delivery of 100 bottles of Plaquenil 200 mg tablets. The contract has a completion date of March 9, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the supply of Chloroquine PH 500 mg tablets in quantities of 25 units, with a ceiling value of $14,677.16. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 22, 2025. This award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7Z0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Plaquemin 200 mg tablets (100-count packages) under a firm fixed-price contract with a ceiling value of $1,510.42. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same city. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to the military healthcare system, enabling the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/1/25 |